EDESA BIOTECH, INC.: 10-K filed 2014-11-21
What EDESA BIOTECH, INC. reported in its annual report filed 2014-11-21 (fiscal FY 2014): 26 published measures, 69 facts as tagged in accession 0001144204-14-070289.
This filing
- Form
- 10-K (annual report)
- Filed
- 2014-11-21
- Fiscal period
- fiscal FY 2014
- Accession
- 0001144204-14-070289 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All EDESA BIOTECH, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-08-31 | 14,473,962 | USD | |
| At 2013-08-31 | 8,513,358 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-08-31 | 6,773,329 | USD | |
| At 2013-08-31 | 10,709,357 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-08-31 | 7,700,633 | USD | |
| At 2013-08-31 | -2,195,999 | USD | |
| At 2012-08-31 | 902,156 | USD | |
| At 2011-08-31 | 3,440,599 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-08-31 | 13,427,404 | USD | |
| At 2013-08-31 | 7,859,889 | USD | |
| At 2012-08-31 | 998,998 | USD | |
| At 2011-08-31 | 4,145,492 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-09-01 to 2014-08-31 | -8,439,523 | USD | 365 |
| 2012-09-01 to 2013-08-31 | -14,495,779 | USD | 365 |
| 2011-09-01 to 2012-08-31 | -5,529,278 | USD | 366 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-09-01 to 2014-08-31 | 279,065 | USD | 365 |
| 2012-09-01 to 2013-08-31 | 9,541 | USD | 365 |
| 2011-09-01 to 2012-08-31 | 78,338 | USD | 366 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-09-01 to 2014-08-31 | 372,132 | USD | 365 |
| 2012-09-01 to 2013-08-31 | 545,469 | USD | 365 |
| 2011-09-01 to 2012-08-31 | 286,054 | USD | 366 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-08-31 | -33,620,190 | USD | |
| At 2013-08-31 | -25,180,667 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-09-01 to 2014-08-31 | 27,200 | USD | 365 |
| 2012-09-01 to 2013-08-31 | 800 | USD | 365 |
| 2011-09-01 to 2012-08-31 | 800 | USD | 366 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-08-31 | 387,392 | USD | |
| At 2013-08-31 | 246,269 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-09-01 to 2014-08-31 | 956,634 | USD | 365 |
| 2012-09-01 to 2013-08-31 | 786,585 | USD | 365 |
| 2011-09-01 to 2012-08-31 | 1,923,200 | USD | 366 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-08-31 | 14,070,670 | USD | |
| At 2013-08-31 | 8,134,522 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-08-31 | 1,420,666 | USD | |
| At 2013-08-31 | 3,874,158 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-08-31 | 0 | USD | |
| At 2013-08-31 | 116,667 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-08-31 | 55,713 | USD | |
| At 2013-08-31 | 17,648 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-09-01 to 2014-08-31 | 6,090,648 | USD | 365 |
| 2012-09-01 to 2013-08-31 | 4,393,388 | USD | 365 |
| 2011-09-01 to 2012-08-31 | 6,832,053 | USD | 366 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-09-01 to 2014-08-31 | 2,458,934 | USD | 365 |
| 2012-09-01 to 2013-08-31 | 2,018,554 | USD | 365 |
| 2011-09-01 to 2012-08-31 | 2,634,119 | USD | 366 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-08-31 | 78,268,850 | shares | |
| At 2013-08-31 | 57,946,160 | shares |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-08-31 | 893,126 | USD | |
| At 2013-08-31 | 641,267 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-08-31 | 505,734 | USD | |
| At 2013-08-31 | 394,998 | USD |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-09-01 to 2014-08-31 | 2,871,455 | USD | 365 |
| 2012-09-01 to 2013-08-31 | 1,770,619 | USD | 365 |
| 2011-09-01 to 2012-08-31 | 3,662,009 | USD | 366 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-09-01 to 2014-08-31 | 158,313 | USD | 365 |
| 2012-09-01 to 2013-08-31 | 124,833 | USD | 365 |
| 2011-09-01 to 2012-08-31 | 112,144 | USD | 366 |
Amortization of intangible assets
Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-09-01 to 2014-08-31 | 26,191 | USD | 365 |
| 2012-09-01 to 2013-08-31 | 28,571 | USD | 365 |
| 2011-09-01 to 2012-08-31 | 28,572 | USD | 366 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-09-01 to 2014-08-31 | -2,693,807 | USD | 365 |
| 2012-09-01 to 2013-08-31 | -10,647,060 | USD | 365 |
| 2011-09-01 to 2012-08-31 | 1,017,521 | USD | 366 |
Income taxes paid, net
Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-09-01 to 2014-08-31 | 30,200 | USD | 365 |
| 2012-09-01 to 2013-08-31 | 800 | USD | 365 |
| 2011-09-01 to 2012-08-31 | 800 | USD | 366 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-09-01 to 2014-08-31 | -121,075 | USD | 365 |
| 2012-09-01 to 2013-08-31 | 192,067 | USD | 365 |
| 2011-09-01 to 2012-08-31 | -29,740 | USD | 366 |
Inspect the source
- Entity
- EDESA BIOTECH, INC. / CIK 0001540159
- Captured
- 2026-09-20T09:17:32.413Z
- SEC response SHA-256
0f44de1ccf1eff46a1af17dc21d4a3bb38216bbf46e813f5a136d29e08bfd65d
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001540159.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))